close
close

Jaguar Health to showcase at HC Wainwright’s annual Global Investment Conference from September 9-11

Jaguar Health to showcase at HC Wainwright’s annual Global Investment Conference from September 9-11

SAN FRANCISCO, CA / ACCESSWIRE / September 6, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) has decided that Lisa Conte, Founder, Chairman and CEO of the Company, will be presented virtually and meet virtually with investors at the 26th Annual Global Investment Conference, September 9-11, 2024.

Information about Jaguar Health’s presentation at the 26th Annual HC Wainwright Global Investment Conference

When: Virtuelle On-Demand-Präsentation from 7:00 Uhr Eastern am Montag, September 9, 2024 published

Webcast link: Click here here um auf die Präsentation zuzugreifen

Wed: The Conference will take place virtually and in person at Lotte New York Palace, 455 Madison Avenue at 50th Street, New York City.

To register for the Teilnahme an der Konferenz, click here

About the Jaguar Health Human Family

Jaguar Health, Inc. (Jaguar) is a pharmaceutical company that has won the new company, which has won a new company, which is engaged in an exceptionally active field of work namely Sind, zu dem Symptom wie chronic lähmender Durchfall, indigestion, intestinal continence and crampy pains hear. The Jaguar family company Napo Pharmaceuticals (Napo) specializes in the development and sale of prescription medicines for the people for the undisturbed care and the managementvernachlässigter gastro-intestinal symptom with more complicated disease symptoms. The Crofelemer of Napo is of the FDA under the brand name Mytesi® for the symptomatic alleviation of non-infectious diseases during HIV/AIDS treatment under antiretroviral therapies. The Jaguar family of Napo Therapeutics is an Italian Unternehmen Jaguar, which was founded in 2021 in Milan, Italy, and thus receives the help of the crofelemer in Europe and is engaged in the selection of selene and/or other selene krankheiten concentrates. Jaguar Animal Health is a trade name of Jaguar. Magdalena Biosciences, a joint venture between Jaguar and Filament Health Corp., working with Jaguar’s Entheogen Therapeutics Initiative (ETI), has developed a new drug that has received a new drug, which has delivered its Pflanzen for the enormous won healthcare.

More information about:

Jaguar Health, see https://jaguar.health

Napo Pharmaceuticals, see www.napopharma.com

Napo Therapeutics, as seen on napotherapeutics.com

Magdalena Biosciences, see magdalenabiosciences.com

Check this out Make cancer less shitty “-Patient Retirement Program at makecancerlessshitty.com and on X, Facebook and Instagram

Future-oriented excursions

Bestimmte Aussagen in dieser Pressemitteilung set “zukunftsgerichtte Aussagen” dar. After Jaguar-Management at HC Wainwright’s 26th Annual Global Investment Conference a while back, Jaguar’s government was launched. In einigen Fällen können Sie zkunftsgerichtte Aussagen en Begriffen wie “können”, “werden”, “solllten”, “erwarten”, “planen”, “anstreben”, “antizipieren”, “könnten”, “beabsichtigen”, “anstreben”, “projizieren”, “erwägen”, “glauben”, “schätzen”, “vorhersagen”, “potenziell” or “fortsetzen” or the Verneinung dieser Begriffe or others ähnlichen Ausdrücken recognise. When the targeted printing is handled on the printing press, it is completely in the foreground. Jaguar hat that has future-oriented, is supported by its active operation and predictions about future events. These targeted programs are now achieved by the time point of the press and lead to more risks, uncertainties and anahmen, some of which would not be made quantifiable or earlier and one of Jaguar’s controls lie. While the factory does not have a Jaguar factory, the future-oriented data used herein is used to activate their activities or revidieren, they are new information, future revelations, changed surroundings or from other sources.

Contact:

[email protected]

Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

Watch the original press conference at accesswire.com